Published 2 years ago

Moderna first-quarter profit triples on robust vaccine sales

Summary by Ground News

Vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion from $1.73 billion in last year's quarter. More than 217 million doses of Moderna's Spikevax vaccine have been administered in the U.S., where it is one of three approved options for adults.

0 Articles

All

Left

Center

Right

Associated Press News

Moderna first-quarter profit triples on robust vaccine sales

COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter. The vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion

2 years ago·United States

Read Full Article

abc News

Moderna Q1 profit triples on robust COVID vaccine sales

COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter

2 years ago·United States

Read Full Article

Washington Times

Moderna first-quarter profit triples on robust vaccine sales

COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter.

2 years ago·United States

Read Full Article

KRDO

Moderna first-quarter profit triples on robust vaccine sales

By TOM MURPHY AP Health WriterCAMBRIDGE, Mass. (AP) — COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter. The vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion from $1.73 billion in last year’s quarter, when the vaccines were debuting in most markets. More than 217 million doses of Moderna’s Spikevax vaccine have been administered in the U.S., …

2 years ago·Colorado Springs, United States

Read Full Article